Redox modulation of cellular stress response and lipoxin A4 expression by Coriolus versicolor in rat brain: Relevance to Alzheimer's disease pathogenesis

NeuroToxicology

Volumn 53, Issue , 2016, Pages 350-358

  Trovato Salinaro, Angela ^a   Siracusa, R ^b   Di Paola, R ^b   Scuto, M ^a   Fronte, V ^a   Koverech, G ^a   Luca, M ^a   Serra, A ^a   Toscano, M A ^a   Petralia, A ^a   Cuzzocrea, S ^b   Calabrese, V ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Alzheimer's disease; Heat shock protein70; Heme oxygenase 1; Lipoxin A4; Nutritional mushrooms; Vitagenes

Indexed keywords

CYCLOOXYGENASE 2; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEME OXYGENASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOXIN A; NATURAL PRODUCT; THIOREDOXIN; TRANSCRIPTION FACTOR RELA; I KAPPA B; LIPOXIN; RELA PROTEIN, RAT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; FRUITING BODY; FUNGAL BIOMASS; GENE; HIPPOCAMPUS; INTRACELLULAR SIGNALING; MALE; MYCELIUM; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SEPTUM PELLUCIDUM; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; TRAMETES VERSICOLOR; TREATMENT DURATION; UPREGULATION; VITAGENE; ANIMAL; BRAIN; CHEMISTRY; COPRINUS; DRUG EFFECTS; KIDNEY; LIVER; LYMPHOCYTE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; COPRINUS; CYCLOOXYGENASE 2; HEME OXYGENASE-1; I-KAPPA B PROTEINS; KIDNEY; LIPOXINS; LIVER; LYMPHOCYTES; MALE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; THIOREDOXINS; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84951040923     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2015.09.012     Document Type: Article

References (51)

1. Abdelmoaty S., Wigerblad G., Bas D.B., Codeluppi S., Fernandez-Zafra T., El-Awady el-S., Moustafa Y., Abdelhamid Ael-D., Brodin E., Svensson C.I. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. PLoS ONE 2013, e75543. (eCollection 2013). 10.1371/journal.pone.0075543.
2. Blair L.J., Baker J.D., Sabbagh J.J., Dickey C.A. The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing and Alzheimer's disease. J. Neurochem. 2015, (Jan). [Epub ahead of print]. 10.1111/jnc.13033.
3. Brehme M., Voisine C., Rolland T., Wachi S., Soper J.H., Zhu Y., Orton K., Villella A., Garza D., Vidal M., Ge H., Morimoto R.I. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell. Rep. 2014, 9:1135-1150.
4. Buratti L., Balestrini S., Altamura C., Viticchi G., Falsetti L., Luzzi S., Provinciali L., Vernieri F., Silvestrini M. Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease. J. Alzheimers Dis. 2015, (Jan). [Epub ahead of print].
5. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Calabrese E.J., Mattson M.P. Cellular stress responses, the hormesis paradigm and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox. Signal 2010, 13:1763-1811.
6. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Calabrese E.J. Vitagenes, cellular stress response and acetylcarnitine: relevance to hormesis. Biofactors 2009, 35:146-160.
7. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., Cuzzocrea S., Rizzarelli E., Calabrese E.J. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim. Biophys. Acta 2012, 1822:753-783.
8. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Trovato Salinaro A., Cornelius C., Koverech G., Koverech A., Scuto M., Lodato F., Fronte V., Muccilli V., Reibaldi M., Longo A., Uva M.G., Calabrese V. Cellular stress response, redox status, and vitagenes in glaucoma: a systemic oxidant disorder linked to Alzheimer's disease. Front. Pharmacol. 2014, 5:129. (eCollection 2014). 10.3389/fphar.2014.00129.
9. Calabrese V., Cornelius C., Mancuso C., Barone E., Calafato S., Bates T., Rizzarelli E., Kostova A.T. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front. Biosci. 2009, 14:376-397.
10. Calabrese V., Cornelius C., Rizzarelli E., Owen J.B., Dinkova-Kostova A.T., Butterfield D.A. Nitric oxide in cell survival: a Janus molecule. Antioxid. Redox. Signal 2009, 11:2717-2739.
11. Calabrese V., Fariello R.G. Regional distribution of malonaldehyde in mouse brain. Biochem. Pharmacol. 1988, 37:2287-2288.
12. Calabrese V., Mancuso C., Ravagna A., Perluigi M., Cini C., De Marco C., Butterfield D.A., Stella A.M. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. J. Neurochem. 2007, 101:709-717.
13. Calabrese V., Scapagnini G., Ravagna A., Colombrita C., Spadaro F., Butterfield D.A., Giuffrida Stella A.M. Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech. Ageing Dev. 2004, 125:325-335.
14. Calabrese V., Scapagnini G., Ravagna A., Fariello R.G., Giuffrida Stella A.M., Abraham N.G. Regional distribution of heme oxygenase HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J. Neurosci. Res. 2002, 68:65-75.
15. Calabrese V., Cornelius C., Cuzzocrea S., Iavicoli I., Rizzarelli E., Calabrese E.J. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol. Aspects Med. 2011, 32:279-304.
16. Castellani R.J., Rolston R.K., Smith M.A. Alzheimer disease. Dis. Mon. 2010, 56:484-546.
17. Chen X.Q., Wu S.H., Zhou Y., Tang Y.R. Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complex. PLoS ONE 2013, 8:e67120. 10.1371/journal.pone.0067120.
18. Cornelius C., Koverech G., Crupi R., Di Paola R., Koverech A., Lodato F., Scuto M., Salinaro A.T., Cuzzocrea S., Calabrese E.J., Calabrese V. Osteoporosis and Alzheimer pathology: role of cellular stress response and hormetic redox signaling in aging and bone remodeling. Front. Pharmacol. 2014, 5:120. (eCollection 2014). 10.3389/fphar.2014.00120.
19. Cornelius C., Trovato Salinaro A., Scuto M., Fronte V., Cambria M.T., Pennisi M., Bella R., Milone P., Graziano A., Crupi R., Cuzzocrea S., Pennisi G., Calabrese V. Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes. Immun. Ageing 2013, 10:41. 10.1186/1742-4933-10-41.
20. Cui J., Chisti Y. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol. Adv. 2003, 21:109-122.
21. Cui J., Goh K.K., Archer R., Singh H. Characterisation and bioactivity of protein-bound polysaccharides from submerged-culture fermentation of Coriolus versicolor Wr-74 and ATCC-20545 strains. J. Ind. Microbiol. Biotechnol. 2007, 34:393-402.
22. da Silva A.F., Sartori D., Macedo F.C., Ribeiro L.R., Fungaro M.H., Mantovani M.S. Effects of β-glucan extracted from Agaricus blazei on the expression of ERCC5. CASP9, and CYP1A1 genes and metabolic profile in HepG2 cells. Hum. Exp. Toxicol. 2013, 32:647-654.
23. Dunn H.C., Ager R.R., Baglietto-Vargas D., Cheng D., Kitazawa M., Cribbs D.H., Medeiros R. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. J. Alzheimers Dis. 2015, 43:893-903. 10.3233/JAD-141335.
24. Edrey Y.H., Oddo S., Cornelius C., Caccamo A., Calabrese V., Buffenstein R. Oxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents. J. Neurosci. Res. 2014, 92:195-205.
25. El Enshasy H., Elsayed E.A., Aziz R., Wadaan M.A. Mushrooms and truffles: historical biofactories for complementary medicine in Africa and in the Middle East. Evid. Based Complement. Altern. Med. 2013, 620451. (Epub Review 2013 Nov 20). 10.1155/2013/620451.
26. Elsayed E.A., El Enshasy H., Wadaan M.A., Aziz R. Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications. Mediat. Inflamm. 2014, 2014:805841. (Epub PubMed 2014 Nov 23). 10.1155/2014/805841.
27. Figueiredo-Pereira M.E., Rockwell P., Schmidt-Glenewinkel T., Serrano P. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Front. Mol. Neurosci. 2015, 7(Jan):104. (eCollection 2014). 10.3389/fnmol.2014.00104.
28. Gangemi S., Pescara L., D'Urbano E., Basile G., Nicita-Mauro V., Davì G., Romano M. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp. Gerontol. 2005, 40:612-614.
29. Hawkins K.E., DeMars K.M., Singh J., Yang C., Cho H.S., Frankowski J.C., Doré S., Candelario-Jalil E. Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist BML-111, in a rat model of ischemic stroke. J. Neurochem. 2014, 129:130-142.
30. Jeong S.C., Koyyalamudi S.R., Hughes J., Khoo C., Bailey T., Marripudi K., Park J.P., Kim J.H., Song C.H. Antioxidant and immunomodulating activities of exo-and endopolysaccharide fractions from submerged mycelia cultures of culinary-medicinal mushrooms. Int. J. Med. Mushrooms 2013, 15:251-266.
31. Joshi Y.B., Praticò D. The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype. Front. Cell. Neurosci. 2015, 8:436. (eCollection 2014). 10.3389/fncel.2014.00436.
32. Junn E., Mouradian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J. Neurochem. 2001, 78:374-383.
33. Komura D.L., Ruthes A.C., Carbonero E.R., Gorin P.A., Iacomini M. Water-soluble polysaccharides from Pleurotus ostreatus var. florida mycelial biomass. Int. J. Biol. Macromol. 2014, 70(Sep):354-359. (Epub 2014 Jul 5). 10.1016/j.ijbiomac.2014.06.007.
34. Lee K.H., Morris-Natschke S.L., Yang X., Huang R., Zhou T., Wu S.F., Shi Q., Itokawa H. Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine. J. Tradit. Complement Med. 2012, 2:84-95.
35. Lindequist U., Kim H.W., Tiralongo E., Van Griensven L. Medicinal mushrooms. Evid. Based Complement. Alternat. Med. 2014, 806180. (Epub 2014 Jun 24). 10.1155/2014/806180.
36. Liu F., Xia Y., Parker A.S., Verma I.M. IKK biology. Immunol. Rev. 2012, 246:239-253.
37. McGeer P.L., McGeer E.G. Innate immunity, local inflammation, and degenerative disease. Sci. Aging Knowl. Environ. 2002, 29:re3.
38. Medeiros R., Kitazawa M., Passos G.F., Baglietto-Vargas D., Cheng D., Cribbs D.H., LaFerla F.M. Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice. Am. J. Pathol. 2013, 182:1780-1789.
39. Monro J.A. Treatment of cancer with mushroom products. Arch. Environ. Health 2003, 58:533-537.
40. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997, 20:252-258.
41. Paterson R.R., Lima N. Biomedical effects of mushrooms with emphasis on pure compounds. Biomed. J. 2014, 37:357-368.
42. Pietrzak R.H., Lim Y.Y., Neumeister A., Ames D., Ellis K.A., Harrington K., Lautenschlager N.T., Restrepo C., Martins R.N., Masters C.L., Villemagne V.L., Rowe C.C., Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiatry 2015, (Jan). for the Australian Imaging, Biomarkers, and Lifestyle Research Group, ([Epub ahead of print] PubMed PMID:25629787). 10.1001/jamapsychiatry.2014.2476.
43. Sulistio Y.A., Heese K. The ubiquitin-proteasome system and molecular chaperone deregulation in Alzheimer's disease. Mol. Neurobiol. Jan 7 2015, ([Epub ahead of print] PubMed PMID: 25561438).
44. Uhl G.R. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease. Ann. Neurol. 1998, 43:555-560.
45. Walton E.L. Buried treasure: unlocking the secrets of medicinal mushrooms. Biomed. J. 2014, 37(6):339-342.
46. Wang J., Liu Y.M., Cao W., Yao K.W., Liu Z.Q., Guo J.Y. Anti-inflammation and antioxidant effect of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Metab. Brain Dis. 2012, 27:159-165.
47. Wasser S.P. Medicinal mushroom science: current perspectives, advances, evidences, and challenges. Biomed. J. 2014, 37:345-356.
48. Wu J., Wang A., Min Z., Xiong Y., Yan Q., Zhang J., Xu J., Zhang S. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo. Biochem. Biophys. Res. Commun. 2011, 408:327-382.
49. Xu T., Beelman R.B., Lambert J.D. The cancer preventive effects of edible mushrooms. Anticancer Agents Med. Chem. 2012, 12:1255-1263.
50. Yang F., Xie J., Wang W., Xie Y., Sun H., Jin Y., Xu D., Chen B., Andersson R., Zhou M. Regional arterial infusion with lipoxin A4 attenuates experimental severe acute pancreatitis. PLoS ONE 2014, e108525. (eCollection 2014). 10.1371/journal.pone.0108525.
51. Zhang Y., Ahn Y.H., Benjamin I.J., Honda T., Hicks R.J., Calabrese V., Cole P.A., Dinkova-Kostova A.T. HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway. Chem. Biol. 2011, 18:1355-1361.